Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice

Endocrinology

Volumn 147, Issue 12, 2006, Pages 5893-5900

  Nonogaki, Katsunori ^a   Nozue, Kana ^a   Oka, Yoshitomo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; AGOUTI PROTEIN; FENFLURAMINE; GHRELIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FOOD INTAKE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERPHAGIA; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALORIC RESTRICTION; EATING; FENFLURAMINE; GENE EXPRESSION; HYPERPHAGIA; HYPOTHALAMUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEUROPEPTIDES; PEPTIDE HORMONES; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 33751506108     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0418     Document Type: Article

References (34)

1. Simansky KJ 1996 Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37-42
2. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D 1995 Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546
3. Nonogaki K, Strack AM, Dallman MF, Tecott LH 1998 Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152-1156
4. Nonogaki K 2000 New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549
5. Vickers SP, Clifton PG, Dourish CT, Tecott LH 1999 Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology 143:309-314
6. Vickers SP, Dourish CT, Kennett GA 2001 Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41:200-209
7. Lee MD, Somerville EM, Kennett GA, Dourish CT, Clifton PG 2004 Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology 176:39-49
8. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK 2002 Activation of central melanocortin pathways by fenfluramine. Science 297:609-611
9. Lu D. Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD 1994 Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799-802
10. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
11. Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K 1999 Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033
12. Boston BA, Blaydon KM, Varnerin J, Cone RD 1997 Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278:1641-1644
13. Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, Barsh GS 1999 Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology 140:2387-2397
14. Martin NM, Houston PA, Patterson M, Sajedi A, Carmignac DF, Ghatei MA, Bloom SR, Small CJ 2006 Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes 30:430-438
15. Kojima M, Kangawa K 2005 Ghrelin: structure and function. Physiol Rev 85:495-522
16. Friedman JM 2004 Modern science versus the stigma of obesity. Nat Med 10:563-569
17. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2004 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI3-kinase/AKT. J Cell Biol 159:1029-1037
18. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M, Muccioli G 2004 Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173-184
19. Bedendi I, AllattiG, Marcantoni A, Malan D, Catapano F, Ghe C, Deghenghi R, Ghigo E, Muccioli G 2003 Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol 476:87-95
20. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, Murakami N, Miyazato M, Kangawa K, Nakazato M 2006 Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147:2306-2314
21. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M 2005 Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18-24
22. Chen CY, Inui A, Asakawa A, Fujino K, Kato I, Chen CC, Ueno N, Fujimiya M2005 Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129:8-25
23. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T 2004 Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145:234-242
24. Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, Mulholland MW 2004 Inhibition of adipogenesis by ghrelin. Mol Biol Cell 15:2484-2491
25. Ariyasu H, Takaya K, Iwakura H, Hosoda H, Akamizu T, Arai Y, Kangawa K, Nakao K 2005 Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146:355-364
26. Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981
27. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW 2004 Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101:8227-8232
28. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esternman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
29. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan LL, Wand QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kanagawa K, Nakazato M 2003 Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144:1506-1512
30. Nonogaki K, Ohashi-Nozue K, Oka Y 2006 A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochem Biophys Res Commun 341:703-707
31. Broberger C 1999 Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res 848:101-113
32. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB, Elmquist JK 2001 Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 432:1-19
33. Heisler LK, Tecott LH 2000 A paradoxical locomotor response in serotonin 5-HT(2C) receptor mutant mice. J Neurosci 20:RC71
34. Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT 2000 Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 130:1305-1314